Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Nohara Goto"'
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 4, Pp 3658-3673 (2023)
Cluster of differentiation 44 (CD44) is a type I transmembrane glycoprotein and has been shown to be a cell surface marker of cancer stem-like cells in various cancers. In particular, the splicing variants of CD44 (CD44v) are overexpressed in cancers
Externí odkaz:
https://doaj.org/article/b243de68e8f643f6849c3075db270083
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 3, Pp 1875-1888 (2023)
CD44 has been known as a marker of tumor-initiating cells, and plays pro-tumorigenic functions in many cancers. The splicing variants play critical roles in the malignant progression of cancers by promoting stemness, cancer cell invasion or metastasi
Externí odkaz:
https://doaj.org/article/4f6db199970243e79a0cf1256ff24d17
Autor:
Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Tsunenori Ouchida, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Antibodies, Vol 12, Iss 3, p 45 (2023)
Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC with peritoneal metastasis exhibits a poor prognosis due to the lack of effective therapy. A comprehensive analysis of malignant ascites identified the genomic alte
Externí odkaz:
https://doaj.org/article/4f4857fb3d6b44b89173a572ef9a7035
Autor:
Nohara Goto, Hiroyuki Suzuki, Tomohiro Tanaka, Kenichiro Ishikawa, Tsunenori Ouchida, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Antibodies, Vol 12, Iss 3, p 42 (2023)
Epidermal Growth Factor Receptor (EGFR) overexpression or its mutation mediates the sustaining proliferative signaling, which is an important hallmark of cancer. Human EGFR-targeting monoclonal antibody (mAb) therapy such as cetuximab has been approv
Externí odkaz:
https://doaj.org/article/fc3c797c5b0f4e47aee4bf092707c70e
Autor:
Tomohiro Tanaka, Hiroyuki Suzuki, Yu Isoda, Teizo Asano, Takuro Nakamura, Miyuki Yanaka, Saori Handa, Nozomi Takahashi, Saori Okuno, Takeo Yoshikawa, Guanjie Li, Ren Nanamiya, Nohara Goto, Nami Tateyama, Yuki Okada, Hiyori Kobayashi, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:303-310
Autor:
Ren Nanamiya, Hiroyuki Suzuki, Junko Takei, Guanjie Li, Nohara Goto, Hiroyuki Harada, Masaki Saito, Tomohiro Tanaka, Teizo Asano, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:311-319
Autor:
Yu Isoda, Tomohiro Tanaka, Hiroyuki Suzuki, Teizo Asano, Takuro Nakamura, Miyuki Yanaka, Saori Handa, Yu Komatsu, Saori Okuno, Nozomi Takahashi, Yuki Okada, Hiyori Kobayashi, Guanjie Li, Ren Nanamiya, Nohara Goto, Nami Tateyama, Takeo Yoshikawa, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:275-278
Autor:
Kato, Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Tsunenori Ouchida, Mika K. Kaneko, Yukinari
Publikováno v:
Antibodies; Volume 12; Issue 3; Pages: 45
Gastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC with peritoneal metastasis exhibits a poor prognosis due to the lack of effective therapy. A comprehensive analysis of malignant ascites identified the genomic alte
Autor:
Hiroyuki Suzuki, Yuma Kudo, Mayuki Tawara, Nohara Goto, Kenichiro Ishikawa, Tsunenori Ouchida, Tomohiro Tanaka, Teizo Asano, Takuro Nakamura, Miyuki Yanaka, Mika K. Kaneko, Yukinari Kato
CD39 is involved in adenosine metabolism through conversion of extracellular ATP to adenosine. Because extracellular adenosine plays a critical role in the immune suppression of tumor microenvironment, the inhibition of CD39 activity by monoclonal an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3975bbe33a29ffab98182719dc7e4a8
https://doi.org/10.20944/preprints202304.0032.v1
https://doi.org/10.20944/preprints202304.0032.v1
Autor:
Nohara Goto, Hiroyuki Suzuki, Tomokazu Ohishi, Akiko Harakawa, Guanjie Li, Masaki Saito, Junko Takei, Tomohiro Tanaka, Teizo Asano, Masato Sano, Manabu Kawada, Mika K. Kaneko, Yukinari Kato
Publikováno v:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 41:67-73
The epidermal growth factor receptor (EGFR) is involved in tumor malignancy through gene amplification and/or protein overexpression. An anti-human EGFR (hEGFR) monoclonal antibody (clone EMab-134), which explicitly detects hEGFR and dog EGFR (dEGFR)